SCHEMBL23164297

SCHEMBL23164297

c1ccc(COc2ncc(Nc3ccccc3)cc2-c2cccc3cc[nH]c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 2/20 0.40
▸ KDR P35968 1/20 0.40
▸ IDO1 P14902 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ EGFR P00533 1/20 0.36
▸ TTBK1 Q5TCY1 1/20 0.36
▸ TTBK2 Q6IQ55 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ DYRK1B Q9Y463 2/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ SGMS2 Q8NHU3 1/20 0.36
▸ PTK6 Q13882 1/20 0.36
▸ FGFR1 P11362 1/20 0.36
▸ FGFR2 P21802 1/20 0.36
▸ FGFR3 P22607 1/20 0.36
▸ NR3C1 P04150 2/20 0.36
▸ PGR P06401 1/20 0.36
▸ CTSV O60911 1/20 0.35
▸ CTSL P07711 1/20 0.35
▸ BRD4 O60885 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23163752 0.83 MAPK14 (0.53) CDK1KDREGFRTTBK1TTBK2
SCHEMBL29831310 0.83 MAPK14 (0.53) CDK1KDREGFRTTBK1TTBK2
SCHEMBL23163731 0.79 IKBKE (0.41) KDRKDM4ESGMS2PTK6C5AR1
SCHEMBL23164074 0.78 LIMK1 (0.41) SGMS2CTSVCTSLCYP1A2CYP3A4
SCHEMBL29831471 0.77 SQOR (0.46) KDM4EDYRK1BDYRK1ASGMS2SYK
SCHEMBL23164306 0.77 MAPK14 (0.54) CDK1KDREGFRTTBK1TTBK2
SCHEMBL29831171 0.76 MAPK14 (0.53) CDK1KDREGFRTTBK1TTBK2
SCHEMBL23164316 0.76 MAPK14 (0.53) CDK1KDREGFRTTBK1TTBK2
SCHEMBL23163745 0.76 MAPK14 (0.54) EGFRDYRK1BDYRK1ASGMS2PTK6
SCHEMBL29831299 0.76 MAPK14 (0.54) EGFRAURKBDYRK1BDYRK1ASGMS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351556-B2 Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2025-07-08 — — US disclosed
US-20220363643-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN CENTRE HOSPITALIER UNIVERSITAIRE DE CLERMONT-FD (FR) 2022-11-17 — — US disclosed
EP-4037770-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2022-08-10 — — EP disclosed
WO-2021064186-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2021-04-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363643-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN P2RX3, OPRL1, P2RX6 CDK1 441/4885KDR 2129/4885IDO1 542/4885
US-12351556-B2 Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain P2RX3, P2RX6, P2RX4 CDK1 364/4885KDR 2111/4885IDO1 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback